| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1a48b04f986c44c2ca9129ce0b1d17c6 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12R2001-91 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-12 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
1983-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e7cb31574d448d756230a97c507f7aa5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8124534d31dac25a4e2d0f8c4614a771
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6cccfe942217a4a23a254dda804afc04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f2a3731dab647b24caddcfdc2bdd9cb4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4fd223b8e04ab3d0bec1871d09a4b80a |
| publicationDate |
1984-02-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
GB-2125048-A |
| titleOfInvention |
Process for the production of anti-tumor glycoproteins |
| abstract |
A process for the production of an anti-tumor glycoprotein having a smaller molecular weight than the molecular weight of a starting anti- tumor glycoprotein which comprises using as the starting material an anti- tumor glycoprotein obtained from an extract or a culture supernatant of reticuloendothelial cells, lymphoblasts, leukemia cells or fibroblasts of warm-blooded animals, conducting degradation treatment on said glycoprotein by reacting it with a reducing agent and thereafter recovering an anti-tumor glycoprotein having a reduced molecular weight from the reaction mixture. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2161813-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0594311-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5498697-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5585474-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5827691-A |
| priorityDate |
1982-08-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |